For the past twenty-four years we have offered a Mentor Program to our students. The purpose of this Program is to provide you and a small group of your colleagues with the opportunity to personally discuss any topic of mutual interest with a leading locally-based, nationally recognized health care executive. (Please see mentor list below). To diversify their experience, students choose a different mentor for their second year. Mentor resumes and proposed meeting dates (if any) for each mentor will be available to help your selection. We will distribute the Mentor Lottery Selection forms during the week of September 4, 2008. We are sure that you will find it to be one of the most rewarding educational experiences you will have at Kellogg.
Maneesh Arora is formerly the CFO and VP of Strategies at Third Wave Technologies, Inc. Third Wave Technologies, Inc. develops and markets molecular diagnostics for a variety of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis applications, providing its clinical, research and agricultural customers with molecular solutions. Third Wave's products are based on its Invader chemistry. He received his undergraduate degree in Economics from the University of Chicago and his MBA from the Kellogg School of Management.
Michael Burke is the Chief Commercial Officer at Ovation Pharma. Prior to joining OVATION in 2001, Mike Burke spent nine years at Abbott Laboratories' Pharmaceutical Products Division. At Abbott, Mr. Burke served in various sales and marketing roles, managing specialty market and primary care product lines. As Director of the Neuroscience Business Unit at Abbott PPD, he managed the largest and most profitable specialty pharmaceutical product line: the Depakote® and Depakote® ER (divalproex sodium) family of products. Prior to his neuroscience experience, Mr. Burke was responsible for marketing strategy, promotion development, and sales force support for a leading infectious disease franchise, as well as a urology and cardiovascular product. Before joining Abbott, Mr. Burke was the founder and President of Athwell, a health promotion consulting service company
Arthur Holden is the Founder and CEO of International Serious Adverse Events Consortium (SAEC-2007 - present) and Pharmaceutical Biomedical Research Consortium (PBRC)-2006 to present). The SAEC is an international non-profit organization formed to identify and validate DNA-variants useful in predicting the risk of drug induced serious adverse events [SAEs] and The PBRC is a non-profit organization which serves to advance the field of medicine through the development and implementation of high quality “pre-competitive” biomedical research consortia across the pharmaceutical industry and academia. He received his MBA from the Kellogg School of Management and his undergraduate degree from Union College.
David Loucks is President and Chief Executive of Healthios, Inc. (“Healthios”), a healthcare merchant banking firm. Throughout his professional career, Mr. Loucks has been active as an advisor, investor, and general manager across the global healthcare industry, in the process nurturing a unique perspective on the sources of success and the nature of value creation. Healthios was founded in 2005 by Mr. Loucks, following several years spent as Managing Partner of the Aethena Group, LLC, which is a private equity partnership with a broad portfolio of investment interests. During his tenure with Aethena, Mr. Loucks positioned that firm to become one of the most active investors in the global healthcare industry, having participated in more than (40) transactions from 2001 through 2004, representing aggregate enterprise values in excess of $5 billion. Prior to founding the Aethena, from 1998 until 2000, Mr. Loucks served as President and CEO of Physician Dynamics, Inc. (“PDI”), a fully-integrated provider of patient education and disease management solutions for patients afflicted with chronic and acute diseases. Services comprising patient & family education, compliance management, utilization review, outcomes measurement, informed consent, and remote monitoring were sold to hospitals, health plans, and providers throughout the U.S. Among his duties at Robertson Stephens, Mr. Loucks was a founder of the Special Situations practice and he directed that firm’s first international financing initiatives for companies based in Europe, Israel, India, and China. Schooled in Europe, and later a graduate of the Lawrenceville School, of Yale University, and of the Kellogg Graduate School of Management at Northwestern University, Mr. Loucks is multi-lingual and has spent more than 15 years living and
Gary Mecklenburg is recognized as one of the leading healthcare executives in the nation. On September 1, 2006 he retired after 21 years as president and CEO of Northwestern Memorial HealthCare and Northwestern Memorial Hospital in Chicago. His distinguished career began in 1970, and he has held senior management positions at the University of Wisconsin Hospitals, Stanford University Hospital, and St. Joseph’s Hospital and Franciscan Healthcare in Milwaukee. Mr. Mecklenburg’s national leadership has included serving as chairman of the American Hospital Association, the Illinois Hospital Association, the Health Forum, National Alliance for Information Technology, and the Healthcare Research and Development Institute. He also serves on the boards of the Institute for Healthcare Improvement and the National Center for Healthcare Leadership. Mr. Mecklenburg is a member of three corporate boards: Becton Dickinson, Regency Hospital Company, and Cogent Healthcare. Among his many professional activities, Mr. Mecklenburg has been a passionate advocate for leadership and workforce development, for healthcare information technology, and for improving diversity through mentoring. He is a frequent speaker and university lecturer and serves on the Advisory Board for the Kellogg Graduate School of Management. He recently served as a commissioner on the federal Commission for Systemic Interoperability and also chaired the American Hospital Association’s Commission on Workforce for Hospitals and Health Systems. Mr. Mecklenburg received his Bachelor of Arts degree from Northwestern University and a Master of Business Administration degree from the University of Chicago.
Mr. Terence Mieling has 34 years of healthcare experience with the last 27 in public finance investment banking. From the Chicago office, he is responsible for providing investment banking services to a variety of healthcare clients throughout the country. His clients include Hospital Sisters Health System (WI, IL), Sisters of St. Francis Health Services (IN, IL), Avera Health (SD), MultiCare Health System (WA), Munson Healthcare (MI) and the University of Wisconsin Medical Foundation (WI). Prior to joining Merrill Lynch in 1997, he was National Director for the investment banking firm of John Nuveen & Co. for 17 years. From 1975 through 1980, Mr. Mieling was a Senior Manager with Ernst & Young in Chicago, where he provided consulting services to the health care industries. Prior to Ernst & Young he was a Chief Financial Officer for a hospital in the Hospital Sisters Health System, Springfield, Illinois. Mr. Mieling received his B.S. in Biochemistry from the University of Illinois at Urbana in 1971 and his M.B.A. from the same institution in 1973. In addition, he has been a Certified Public Accountant since 1975.
Mark R. Neaman is President and Chief Executive Officer of Evanston Northwestern Healthcare, Evanston, Illinois, a $1+ billion provider of comprehensive healthcare services. The Corporation includes three Hospitals, a 500-Physician multi-specialty group practice, a $100+ million Foundation, a Research Institute with $100+ million of federal grants, and is an academic affiliate of Northwestern University, where he holds a faculty position of Senior Fellow. Mr. Neaman earned a Bachelor’s Degree from The Ohio State University, Columbus, Ohio, in 1972; and Master’s Degree in Business/Healthcare Administration from Ohio State in 1974.Mr. Neaman began his management career at the Evanston Hospital as an Administrative Assistant in 1974. From 1974 to present, he has held numerous positions at The Hospital and for the Corporation. He was named Chief Executive Officer in January, 1992.Mr. Neaman has served on a variety of healthcare-related organizations. He is a Fellow in the American College of Healthcare Executives (ACHE) and served on the Board of Governors for the College (1997-2004) and was Chairman in 2002-2003. He is a member of the Healthcare Leadership Council (1992-present) and currently serves as the Chairman of the Board. He is a member of the American Hospital Association (AHA); served on the Regional Advisory Board of AHA and the Board of Directors of the Illinois Hospital Association; is a member and was Chairman of the Board (1997-1998) of the National Committee for Quality Health Care in Washington, D.C.; was Chairman of the Board for LifeSource Regional Blood Center (1983-1989) and served on the board of Directors beginning in 1981; is a member of the International Hospital Federation (since 1982); Past President of The Ohio State University Alumni Association (1980-81); served on the Board of Directors for the Heart Association of Northern Cook County (1979-1984); is a Fellow, Institute of Medicine of Chicago; and is a member of the Commercial Club, The Economic Club, and Executives’ Club of Chicago. He is a member of Health Insights (1985-present) and Chairman (1998-2000). He served on the Board of Directors of the VHA Health Foundation, Inc. (1998-2001). Mr. Neaman would like to have students suggest topics and meeting dates.
Olivier Visa is a seasoned Marketing Executive in the Pharmaceutical Industry with Global expertise and responsibilities in both strategic and operational marketing. Olivier’s scope of experience includes both biopharmaceutical and pharmaceutical fields. He’s developed a strong acumen of the industry challenges and opportunities throughout his engagement in Drug Delivery. He’s recognized for his focus on growth and investment through customer-centered business strategy and ruthless execution. Olivier and his family lived in the US, Canada and across Europe. He acquired a diverse cultural understanding through all the countries he worked with: UK, Belgium, Germany, Italy, Spain, France, US and Canada. Additionally, his global responsibilities led him to build business relationships with Japan, China, Australia, New Zealand, Latin America and Eastern Europe. After 14 years of increased responsibilities in sales and marketing, Olivier is now leading the launch of a newly approved biological compound in the context of a strategic alliance between Baxter and a small San-Diego based Biotech. Pharm.D, trained in Customer Centric Marketing at IMD, Lausanne – Switzerland, he’s an alumni of the Kellogg School of Management where he earned his MBA (EMP61) in 2005. Additional responsibilities as a Board Member and Chairman for fund-raising at the French American Chamber of Commerce based in Chicago drive him to play a significant role in the economic relationships between the US and France, his native country.
Download Mentor Selection Form